CME · XBRL financial data
Cme Group financial statements, every fiscal year
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (CME's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 4,884 | 4,690 | 5,019 | 5,579 | 6,130 | 6,521 |
| Operating income (loss) | 2,637 | 2,645 | 3,016 | 3,436 | 3,932 | 4,230 |
| Other income (expense) | (122) | 343 | (1,862) | (4,695) | (3,659) | (4,834) |
| Income tax expense (benefit) | 616 | 737 | 799 | 927 | 1,016 | 1,258 |
| Net income (loss) | 2,105 | 2,636 | 2,691 | 3,226 | 3,526 | 4,072 |
| Earnings per share, basic USD per share | 5.88 | 7.30 | 7.41 | 8.87 | 9.69 | 11.18 |
| Earnings per share, diluted USD per share | 5.87 | 7.29 | 7.40 | 8.86 | 9.67 | 11.16 |
| Weighted average shares, basic millions of shares | 358 | 358 | 359 | 359 | 359 | 360 |
| Weighted average shares, diluted millions of shares | 359 | 359 | 359 | 360 | 360 | 360 |
Balance sheet
CSVFiscal years (CME's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 1,633 | 2,835 | 2,720 | 2,912 | 2,892 | 4,417 |
| Marketable securities | 101 | 115 | 96 | 112 | 113 | 125 |
| Accounts receivable | 461 | 435 | 483 | 536 | 573 | 639 |
| Total current assets | 89,284 | 161,762 | 139,078 | 94,890 | 103,034 | 165,359 |
| Property and equipment, net | 579 | 505 | 456 | 410 | 386 | 363 |
| Right-of-use asset | 390 | 345 | 311 | 272 | 231 | 210 |
| Goodwill | 10,799 | 10,528 | 10,483 | 10,495 | 10,487 | 10,515 |
| Total assets | 124,660 | 196,780 | 174,176 | 129,706 | 137,447 | 198,424 |
| Accounts payable | 69 | 49 | 121 | 91 | 80 | 72 |
| Total current liabilities | 88,198 | 160,398 | 137,688 | 93,417 | 102,314 | 160,297 |
| Lease liability, non-current | 492 | 449 | 384 | 344 | 289 | 237 |
| Total liabilities | 98,308 | 169,381 | 147,297 | 102,968 | 110,960 | 169,696 |
| Retained earnings | 4,996 | 5,152 | 4,747 | 4,455 | 4,186 | 6,433 |
| Total stockholders' equity | 26,320 | 27,399 | 26,879 | 26,738 | 26,487 | 28,728 |
| Total liabilities and equity | 124,660 | 196,780 | 174,176 | 129,706 | 137,447 | 198,424 |
Cash flows
CSVFiscal years (CME's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 2,105 | 2,636 | 2,691 | 3,226 | 3,526 | 4,072 |
| Stock-based compensation | 96 | 75 | 84 | 83 | 90 | 95 |
| Net cash from operating activities | 2,716 | 2,402 | 3,056 | 3,454 | 3,691 | 4,277 |
| Purchases of property and equipment | 198 | 127 | 90 | 76 | 94 | 84 |
| Net cash from investing activities | (176) | 58 | (490) | 21 | (83) | 1,499 |
| Dividends paid | 2,110 | 2,189 | 2,634 | 3,236 | 3,584 | 3,933 |
| Proceeds from long-term debt | 0 | — | — | — | — | — |
| Net cash from financing activities | (2,458) | 69,909 | (25,382) | (48,339) | 5,077 | 56,510 |
| Net change in cash | 82 | 72,370 | (22,816) | (44,865) | 8,684 | 62,285 |
Compare with peers
SIC 6200 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 6200 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Cme Group | 2,199 | 1,737 | 1,086* | not reported | 10-QSep 30, 2026 |
| Intercontinental Exchange | 936 | 3,630 | 1,162* | 558.9M | 10-QSep 30, 2026 |
| Nasdaq | 365 | 2,393 | 521* | 555.0M | 10-QSep 30, 2026 |
| LPL Financial Holdings | 1,059 | 5,344 | 297* | 77.9M | 10-QSep 30, 2026 |
| Cboe Global Markets | 2,663 | 1,359 | 817* | 104.3M | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.